3 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
While the MiniMed™ 780G AID system use is associated with low CGM-derived hypoglycemia exposure and highly effective glycemic control, regardless of customized settings, superior glycemic control is associated with a higher proportion of user-initiated manual boluses.
Current clinical evidence supports its use mainly in selected patients rather than as a universal default strategy, and recent updates to major international guidelines are discussed, reflecting a shift toward individualized, comorbidity-focused treatment selection.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
